Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5-year prospective cohort study

被引:138
作者
Park, Sung Keun [1 ]
Seo, Mi Hae [2 ]
Shin, Ho Cheol [3 ]
Ryoo, Jae-Hong [4 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Total Healthcare Ctr, Kangbuk Samsung Hosp, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Kangbuk Samsung Hosp, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Dept Family Med, Kangbuk Samsung Hosp, Seoul, South Korea
[4] Kyung Hee Univ, Dept Prevent Med, Sch Med, Seoul 130701, South Korea
关键词
BETA-CELL FUNCTION; INSULIN-RESISTANCE; PREVALENCE; GLUCOSE;
D O I
10.1002/hep.26183
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There have been several reports about the clinical association between type 2 diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). However, most of the studies were about the unilateral effects of type 2 DM on NAFLD, and studies on the reverse relation are rare. Thus, this study was designed to investigate the effect of NAFLD on type 2 DM. We conducted a prospective cohort study on 25,232 Korean men without type 2 DM for 5 years. We serially checked the various metabolic factors including fasting glucose and hemoglobin A1c (HbA1c), and monitored the development of type 2 DM. The incidence rate of type 2 DM was compared according to the degree of NAFLD (normal, mild, and moderate to severe), and a Cox proportional hazards model was used to measure the hazard ratios (HRs) of NAFLD on type 2 DM. The incidence rate of type 2 DM increased according to the degree of NAFLD (normal: 7.0%, mild: 9.8%, moderate to severe: 17.8%, P < 0.001). Even after adjusting for other multiple covariates, the HRs (95% confidence interval [CI]) for type 2 DM development was higher in the mild group (1.09; 0.81-1.48) and moderate to severe group (1.73; 1.00-3.01) compared to the normal group, respectively (P for trend <0.001). Conclusion: The development of type 2 DM is potentially more associated with more progressive NAFLD than a normal or milder state. In addition, NAFLD was an independent risk factor for the future development of type 2 DM. These results suggest the potential availability of NAFLD as an early predictor of type 2 DM. (HEPATOLOGY 2013;57:13781383)
引用
收藏
页码:1378 / 1383
页数:6
相关论文
共 50 条
  • [21] An insight on the additive impact of type 2 diabetes mellitus and nonalcoholic fatty liver disease on cardiovascular consequences
    Bhardwaj, Monika
    Mazumder, Papiya Mitra
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [22] Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study
    Mikolasevic, I.
    Domislovic, V.
    Wensveen, T. Turk
    Delija, B.
    Klapan, M.
    Juric, T.
    Lukic, A.
    Mijic, A.
    Skenderevic, N.
    Puz, P.
    Ostojic, A.
    Krznaric, Z.
    Radic-Kristo, D.
    Kanizaj, T. Filipec
    Stimac, D.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 82 : 68 - 75
  • [23] The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
    Nar, A.
    Gedik, O.
    ACTA DIABETOLOGICA, 2009, 46 (02) : 113 - 118
  • [24] Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men
    Fukuda, Takuya
    Hamaguchi, Masahide
    Kojima, Takao
    Mitsuhashi, Kazuteru
    Hashimoto, Yoshitaka
    Ohbora, Akihiro
    Kato, Takahiro
    Nakamura, Naoto
    Fukui, Michiaki
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (12) : 1443 - 1449
  • [25] Sociodemographic and genetic determinants of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients
    Adnan, Muhammad
    Wajid, Abdul
    Noor, Wasif
    Batool, Andleeb
    Aasim, Muhammad
    Abbas, Kamran
    Ain, Quratul
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2022, 20 (01)
  • [26] Exploring Biomarkers in Nonalcoholic Fatty Liver Disease Among Individuals With Type 2 Diabetes Mellitus
    Ahmadizar, Fariba
    Younossi, Zobair M.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2025, 59 (01) : 36 - 46
  • [27] Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
    Mantovani, Alessandro
    Targher, Giovanni
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (13)
  • [28] Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice
    Sun, JuanJuan
    Wang, Hui-juan
    Yu, Jun
    Li, TingTing
    Han, YiDi
    FOOD SCIENCE & NUTRITION, 2020, 8 (11): : 6207 - 6216
  • [29] Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study
    Garcia-Escobar, E.
    Valdes, S.
    Soriguer, F.
    Vendrell, J.
    Urrutia-Etxebarria, I. M.
    Maldonado-Araque, C.
    Ortega, E.
    Ocon, P.
    Montanya, E.
    Menendez, E.
    Lago-Sampedro, A.
    Gonzalez-Frutos, T.
    Gomis, R.
    Goday, A.
    Garcia-Serrano, S.
    Galan-Garcia, J. L.
    Castell, C.
    Bordiu, E.
    Badia, R.
    Aguilera-Venegas, G.
    Girbes, J.
    Gaztambide, S.
    Delgado, E.
    Chaves, F. J.
    Castano, L.
    Calle-Pascual, A.
    Rojo-Martinez, G.
    Franch-Nadal, J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study
    Huh, Ji Hye
    Kim, Jang Young
    Choi, Eunhee
    Kim, Jae Seok
    Chang, Yoosoo
    Sung, Ki-Chul
    PLOS ONE, 2017, 12 (07):